| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:51:59 UTC |
|---|
| HMDB ID | HMDB0015422 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Cefazolin |
|---|
| Description | Cefazolin is only found in individuals that have used or taken this drug. It is a semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. [PubChem]In vitro tests demonstrate that the bactericidal action of cephalosporins results from inhibition of cell wall synthesis. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. |
|---|
| Structure | [H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ChEBI | | Cefamezin | ChEBI | | Cefazolina | ChEBI | | Cefazoline | ChEBI | | Cefazolinum | ChEBI | | Cephamezine | ChEBI | | Cephazolidin | ChEBI | | Cephazolin | ChEBI | | Cephazoline | ChEBI | | CEZ | ChEBI | | (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Generator | | (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Generator | | (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Generator | | Cefamedin | HMDB | | Cefamezine | HMDB | | Sodium cephazolin | HMDB | | Sodium, cefazolin | HMDB | | Sodium, cephazolin | HMDB | | Gramaxin | HMDB | | Ancef | HMDB | | Cefazolin sodium | HMDB | | Cephazolin sodium | HMDB | | Cephazolin, sodium | HMDB | | Kefzol | HMDB | | Totacef | HMDB |
|
|---|
| Chemical Formula | C14H14N8O4S3 |
|---|
| Average Molecular Weight | 454.507 |
|---|
| Monoisotopic Molecular Weight | 454.030013046 |
|---|
| IUPAC Name | (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|---|
| Traditional Name | cefazolin |
|---|
| CAS Registry Number | 25953-19-9 |
|---|
| SMILES | [H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1 |
|---|
| InChI Key | MLYYVTUWGNIJIB-BXKDBHETSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Lactams |
|---|
| Sub Class | Beta lactams |
|---|
| Direct Parent | Cephalosporins |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cephalosporin
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Aryl thioether
- Alkylarylthioether
- Meta-thiazine
- Azole
- Heteroaromatic compound
- Tertiary carboxylic acid amide
- Tetrazole
- Thiadiazole
- Azetidine
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Monocarboxylic acid or derivatives
- Dialkylthioether
- Sulfenyl compound
- Hemithioaminal
- Thioether
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Carbonyl group
- Hydrocarbon derivative
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.49 g/L | Not Available | | LogP | -0.58 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.93 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.9371 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.16 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 52.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1700.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 214.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 93.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 151.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 58.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 278.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 424.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 199.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 744.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 314.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1377.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 265.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 265.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 403.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 209.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 257.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Cefazolin,1TMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C)N3C(=O)[C@@H](NC(=O)CN4C=NN=N4)[C@H]3SC2)S1 | 4215.0 | Semi standard non polar | 33892256 | | Cefazolin,1TMS,isomer #2 | CC1=NN=C(SCC2=C(C(=O)O)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C)[C@H]3SC2)S1 | 4063.6 | Semi standard non polar | 33892256 | | Cefazolin,2TMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C)[C@H]3SC2)S1 | 3985.4 | Semi standard non polar | 33892256 | | Cefazolin,2TMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C)[C@H]3SC2)S1 | 3379.7 | Standard non polar | 33892256 | | Cefazolin,2TMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C)[C@H]3SC2)S1 | 6439.8 | Standard polar | 33892256 | | Cefazolin,1TBDMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C(C)(C)C)N3C(=O)[C@@H](NC(=O)CN4C=NN=N4)[C@H]3SC2)S1 | 4422.5 | Semi standard non polar | 33892256 | | Cefazolin,1TBDMS,isomer #2 | CC1=NN=C(SCC2=C(C(=O)O)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C(C)(C)C)[C@H]3SC2)S1 | 4280.1 | Semi standard non polar | 33892256 | | Cefazolin,2TBDMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C(C)(C)C)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C(C)(C)C)[C@H]3SC2)S1 | 4376.0 | Semi standard non polar | 33892256 | | Cefazolin,2TBDMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C(C)(C)C)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C(C)(C)C)[C@H]3SC2)S1 | 3757.5 | Standard non polar | 33892256 | | Cefazolin,2TBDMS,isomer #1 | CC1=NN=C(SCC2=C(C(=O)O[Si](C)(C)C(C)(C)C)N3C(=O)[C@@H](N(C(=O)CN4C=NN=N4)[Si](C)(C)C(C)(C)C)[C@H]3SC2)S1 | 6319.4 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Cefazolin GC-MS (Non-derivatized) - 70eV, Positive | splash10-05ai-9331300000-a190d4fa6f7addfc7f8c | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cefazolin GC-MS (1 TMS) - 70eV, Positive | splash10-00e9-9310500000-949cf3462e4c45379627 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cefazolin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cefazolin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin LC-ESI-QTOF , positive-QTOF | splash10-05fr-0109500000-d35195620e6ac4356773 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin LC-ESI-QTOF , positive-QTOF | splash10-0aba-0943000000-da64d40a841f7fe440fe | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin LC-ESI-QTOF , positive-QTOF | splash10-0zfr-0910000000-f074c2d1d56b5f3da552 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin LC-ESI-QTOF , positive-QTOF | splash10-0q2i-0900000000-bbd7d226d641cfe51521 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin LC-ESI-QTOF , positive-QTOF | splash10-0l1r-0900000000-18addd569fa36108660e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 40V, Positive-QTOF | splash10-0pvi-0900000000-287aa1c6700ef519dedb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 40V, Positive-QTOF | splash10-0q2i-0900000000-9e7cde1888a3978aed23 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 10V, Positive-QTOF | splash10-05fr-0109500000-d35195620e6ac4356773 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 20V, Positive-QTOF | splash10-0aba-0953000000-486d054de7bf3c3c59f8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 40V, Positive-QTOF | splash10-0q2i-0900000000-854b2bd437ac40b2e4b9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 30V, Positive-QTOF | splash10-0zfr-0910000000-c1f36584835748883d05 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 20V, Positive-QTOF | splash10-05fs-0943000000-663a761fef5117d13f02 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 30V, Positive-QTOF | splash10-0zfr-0920000000-30e9df76adf5b0ab0e2e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 10V, Positive-QTOF | splash10-05fr-0109500000-a3dc371ba38a25191014 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 50V, Positive-QTOF | splash10-0l1r-0900000000-ec13af7a17d51561e88a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 50V, Positive-QTOF | splash10-0q39-0900000000-7fdfdaaae2066b530d9e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 40V, Positive-QTOF | splash10-0pvi-0900000000-32fabc5e15ec2390ad50 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 40V, Positive-QTOF | splash10-0q2i-0900000000-bbd7d226d641cfe51521 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cefazolin 30V, Positive-QTOF | splash10-0zfr-0910000000-f074c2d1d56b5f3da552 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefazolin 10V, Positive-QTOF | splash10-0ap0-2749700000-4a77f2bfb0a94e40248a | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefazolin 20V, Positive-QTOF | splash10-00di-9442000000-ae982fa3122bc6aa8c09 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefazolin 40V, Positive-QTOF | splash10-0a6r-9328000000-5482d1c278b4443581ce | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefazolin 10V, Negative-QTOF | splash10-00xu-9311000000-fc7869714720e58c02c6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefazolin 20V, Negative-QTOF | splash10-001i-4920000000-c40df0bab8447e63198d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefazolin 40V, Negative-QTOF | splash10-066r-9143000000-9ff6c941993091c7a3f9 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|